As part of our Market Sentiment Analysis program we’re continuing our technical analysis of equities and markets with a look at Pfizer over the last few months since July 1. The value of PFE went up and then back down a bit over that timeframe. We highlight the ESG score in this dashboard (that’s Environmental, Social and Corporate Governance) and the likely impact of ESG on long term value. In this case, we see that the PFE valuation is more a reflection of the overall Pharmaceuticals industry, rather than factors specific to Pfizer.
To see the full dashboard, take a look here.
